Annual Total Liabilities
$2.79 B
-$763.10 M-21.45%
December 31, 2024
Summary
- As of February 25, 2025, BIO annual total liabilities is $2.79 billion, with the most recent change of -$763.10 million (-21.45%) on December 31, 2024.
- During the last 3 years, BIO annual total liabilities has fallen by -$1.32 billion (-32.07%).
- BIO annual total liabilities is now -32.07% below its all-time high of $4.11 billion, reached on December 31, 2021.
Performance
BIO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$2.79 B
-$320.81 M-10.30%
December 31, 2024
Summary
- As of February 25, 2025, BIO quarterly total liabilities is $2.79 billion, with the most recent change of -$320.81 million (-10.30%) on December 31, 2024.
- Over the past year, BIO quarterly total liabilities has dropped by -$763.96 million (-21.47%).
- BIO quarterly total liabilities is now -39.52% below its all-time high of $4.62 billion, reached on September 30, 2021.
Performance
BIO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
BIO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.4% | -21.5% |
| 3 y3 years | -32.1% | -28.1% |
| 5 y5 years | +24.0% | -28.1% |
BIO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.1% | at low | -33.3% | at low |
| 5 y | 5-year | -32.1% | +24.0% | -39.5% | +24.0% |
| alltime | all time | -32.1% | +6618.3% | -39.5% | +6618.3% |
Bio-Rad Laboratories Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.79 B(-21.4%) | $2.79 B(-10.3%) |
| Sep 2024 | - | $3.12 B(+7.1%) |
| Jun 2024 | - | $2.91 B(-18.2%) |
| Mar 2024 | - | $3.56 B(+0.0%) |
| Dec 2023 | $3.56 B(-8.5%) | $3.56 B(+2.2%) |
| Sep 2023 | - | $3.48 B(-1.5%) |
| Jun 2023 | - | $3.53 B(-9.5%) |
| Mar 2023 | - | $3.90 B(+0.4%) |
| Dec 2022 | $3.89 B(-5.5%) | $3.89 B(+7.8%) |
| Sep 2022 | - | $3.60 B(-4.1%) |
| Jun 2022 | - | $3.76 B(-10.3%) |
| Mar 2022 | - | $4.19 B(+1.9%) |
| Dec 2021 | $4.11 B(+33.0%) | $4.11 B(-11.0%) |
| Sep 2021 | - | $4.62 B(+31.2%) |
| Jun 2021 | - | $3.52 B(+6.0%) |
| Mar 2021 | - | $3.32 B(+7.5%) |
| Dec 2020 | $3.09 B(+37.2%) | $3.09 B(-3.2%) |
| Sep 2020 | - | $3.20 B(+16.5%) |
| Jun 2020 | - | $2.74 B(+14.7%) |
| Mar 2020 | - | $2.39 B(+6.1%) |
| Dec 2019 | $2.25 B(+41.7%) | $2.25 B(+10.2%) |
| Sep 2019 | - | $2.05 B(-5.3%) |
| Jun 2019 | - | $2.16 B(+8.1%) |
| Mar 2019 | - | $2.00 B(+25.7%) |
| Dec 2018 | $1.59 B(+18.5%) | $1.59 B(-12.5%) |
| Sep 2018 | - | $1.82 B(+4.1%) |
| Jun 2018 | - | $1.75 B(+1.2%) |
| Mar 2018 | - | $1.73 B(+28.6%) |
| Dec 2017 | $1.34 B(+5.6%) | $1.34 B(+0.4%) |
| Sep 2017 | - | $1.34 B(+0.4%) |
| Jun 2017 | - | $1.33 B(+7.0%) |
| Mar 2017 | - | $1.25 B(-2.0%) |
| Dec 2016 | $1.27 B(+4.3%) | $1.27 B(-3.5%) |
| Sep 2016 | - | $1.32 B(+4.5%) |
| Jun 2016 | - | $1.26 B(+4.2%) |
| Mar 2016 | - | $1.21 B(-0.8%) |
| Dec 2015 | $1.22 B(+5.5%) | $1.22 B(-1.4%) |
| Sep 2015 | - | $1.24 B(+6.0%) |
| Jun 2015 | - | $1.17 B(+3.4%) |
| Mar 2015 | - | $1.13 B(-2.5%) |
| Dec 2014 | $1.16 B(-3.8%) | $1.16 B(-4.4%) |
| Sep 2014 | - | $1.21 B(-0.7%) |
| Jun 2014 | - | $1.22 B(+0.7%) |
| Mar 2014 | - | $1.21 B(+0.6%) |
| Dec 2013 | $1.20 B(-15.8%) | $1.20 B(+4.0%) |
| Sep 2013 | - | $1.16 B(-18.1%) |
| Jun 2013 | - | $1.41 B(-1.0%) |
| Mar 2013 | - | $1.43 B(-0.2%) |
| Dec 2012 | $1.43 B(+5.6%) | $1.43 B(+4.4%) |
| Sep 2012 | - | $1.37 B(+3.9%) |
| Jun 2012 | - | $1.32 B(-2.3%) |
| Mar 2012 | - | $1.35 B(-0.3%) |
| Dec 2011 | $1.35 B(-11.2%) | $1.35 B(+6.0%) |
| Sep 2011 | - | $1.28 B(-3.2%) |
| Jun 2011 | - | $1.32 B(+1.8%) |
| Mar 2011 | - | $1.30 B(-14.9%) |
| Dec 2010 | $1.52 B(+21.1%) | $1.52 B(+21.4%) |
| Sep 2010 | - | $1.25 B(+2.4%) |
| Jun 2010 | - | $1.22 B(-1.7%) |
| Mar 2010 | - | $1.25 B(-0.9%) |
| Dec 2009 | $1.26 B(+30.0%) | $1.26 B(+0.5%) |
| Sep 2009 | - | $1.25 B(+2.8%) |
| Jun 2009 | - | $1.22 B(+35.7%) |
| Mar 2009 | - | $897.01 M(-7.2%) |
| Dec 2008 | $966.62 M(-3.3%) | $966.62 M(+4.0%) |
| Sep 2008 | - | $929.13 M(-2.4%) |
| Jun 2008 | - | $952.19 M(+1.2%) |
| Mar 2008 | - | $940.77 M(-5.9%) |
| Dec 2007 | $999.90 M(+28.7%) | $999.90 M(+30.5%) |
| Sep 2007 | - | $766.14 M(+1.1%) |
| Jun 2007 | - | $757.94 M(+1.5%) |
| Mar 2007 | - | $746.38 M(-3.9%) |
| Dec 2006 | $776.63 M | $776.63 M(+5.1%) |
| Sep 2006 | - | $738.89 M(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $737.92 M(+3.6%) |
| Mar 2006 | - | $712.13 M(-7.3%) |
| Dec 2005 | $768.61 M(-0.8%) | $768.61 M(-1.1%) |
| Sep 2005 | - | $777.03 M(+1.7%) |
| Jun 2005 | - | $763.93 M(-1.4%) |
| Mar 2005 | - | $774.63 M(-0.0%) |
| Dec 2004 | $774.73 M(+55.9%) | $774.73 M(+43.9%) |
| Sep 2004 | - | $538.53 M(+12.6%) |
| Jun 2004 | - | $478.24 M(-0.2%) |
| Mar 2004 | - | $479.24 M(-3.5%) |
| Dec 2003 | $496.79 M(+47.1%) | $496.79 M(+6.5%) |
| Sep 2003 | - | $466.34 M(+42.7%) |
| Jun 2003 | - | $326.78 M(+0.4%) |
| Mar 2003 | - | $325.39 M(-3.6%) |
| Dec 2002 | $337.62 M(-15.6%) | $337.62 M(-6.9%) |
| Sep 2002 | - | $362.50 M(-0.2%) |
| Jun 2002 | - | $363.21 M(-4.9%) |
| Mar 2002 | - | $381.82 M(-4.6%) |
| Dec 2001 | $400.15 M(-0.4%) | $400.15 M(-2.9%) |
| Sep 2001 | - | $412.18 M(+1.9%) |
| Jun 2001 | - | $404.32 M(+0.2%) |
| Mar 2001 | - | $403.61 M(+0.5%) |
| Dec 2000 | $401.66 M(-10.5%) | $401.66 M(-0.9%) |
| Sep 2000 | - | $405.46 M(-8.4%) |
| Jun 2000 | - | $442.69 M(-2.1%) |
| Mar 2000 | - | $452.36 M(+0.8%) |
| Dec 1999 | $448.80 M(+193.3%) | $448.80 M(+216.3%) |
| Sep 1999 | - | $141.90 M(-0.4%) |
| Jun 1999 | - | $142.50 M(-4.2%) |
| Mar 1999 | - | $148.70 M(-2.8%) |
| Dec 1998 | $153.00 M(-1.4%) | $153.00 M(+2.3%) |
| Sep 1998 | - | $149.60 M(-6.5%) |
| Jun 1998 | - | $160.00 M(-1.4%) |
| Mar 1998 | - | $162.20 M(+4.5%) |
| Dec 1997 | $155.20 M(+53.1%) | $155.20 M(+47.7%) |
| Sep 1997 | - | $105.10 M(+7.6%) |
| Jun 1997 | - | $97.70 M(-6.1%) |
| Mar 1997 | - | $104.10 M(+2.7%) |
| Dec 1996 | $101.40 M(-20.8%) | $101.40 M(-7.7%) |
| Sep 1996 | - | $109.80 M(-6.0%) |
| Jun 1996 | - | $116.80 M(-6.7%) |
| Mar 1996 | - | $125.20 M(-2.2%) |
| Dec 1995 | $128.00 M(-4.4%) | $128.00 M(-1.8%) |
| Sep 1995 | - | $130.40 M(-6.0%) |
| Jun 1995 | - | $138.70 M(-3.8%) |
| Mar 1995 | - | $144.20 M(+7.7%) |
| Dec 1994 | $133.90 M(-10.5%) | $133.90 M(-3.2%) |
| Sep 1994 | - | $138.30 M(-4.6%) |
| Jun 1994 | - | $144.90 M(-2.6%) |
| Mar 1994 | - | $148.70 M(-0.6%) |
| Dec 1993 | $149.60 M(-9.7%) | $149.60 M(-8.0%) |
| Sep 1993 | - | $162.60 M(-5.7%) |
| Jun 1993 | - | $172.50 M(+1.4%) |
| Mar 1993 | - | $170.10 M(+2.7%) |
| Dec 1992 | $165.60 M(+2.0%) | $165.60 M(-0.7%) |
| Sep 1992 | - | $166.70 M(-12.5%) |
| Jun 1992 | - | $190.60 M(+15.8%) |
| Mar 1992 | - | $164.60 M(+1.4%) |
| Dec 1991 | $162.30 M(+22.9%) | $162.30 M(+7.8%) |
| Sep 1991 | - | $150.50 M(+8.0%) |
| Jun 1991 | - | $139.30 M(+1.7%) |
| Mar 1991 | - | $137.00 M(+3.7%) |
| Dec 1990 | $132.10 M(+14.4%) | $132.10 M(+7.0%) |
| Sep 1990 | - | $123.50 M(+2.6%) |
| Jun 1990 | - | $120.40 M(+2.6%) |
| Mar 1990 | - | $117.30 M(+1.6%) |
| Dec 1989 | $115.50 M(+20.6%) | $115.50 M(+5.6%) |
| Sep 1989 | - | $109.40 M(+1.5%) |
| Jun 1989 | - | $107.80 M(+12.5%) |
| Dec 1988 | $95.80 M(+17.0%) | $95.80 M(+17.0%) |
| Dec 1987 | $81.90 M(+40.5%) | $81.90 M(+40.5%) |
| Dec 1986 | $58.30 M(+40.1%) | $58.30 M(+40.1%) |
| Dec 1985 | $41.60 M(-12.4%) | $41.60 M(-12.4%) |
| Dec 1984 | $47.50 M | $47.50 M |
FAQ
- What is Bio-Rad Laboratories annual total liabilities?
- What is the all time high annual total liabilities for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual total liabilities year-on-year change?
- What is Bio-Rad Laboratories quarterly total liabilities?
- What is the all time high quarterly total liabilities for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly total liabilities year-on-year change?
What is Bio-Rad Laboratories annual total liabilities?
The current annual total liabilities of BIO is $2.79 B
What is the all time high annual total liabilities for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual total liabilities is $4.11 B
What is Bio-Rad Laboratories annual total liabilities year-on-year change?
Over the past year, BIO annual total liabilities has changed by -$763.10 M (-21.45%)
What is Bio-Rad Laboratories quarterly total liabilities?
The current quarterly total liabilities of BIO is $2.79 B
What is the all time high quarterly total liabilities for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly total liabilities is $4.62 B
What is Bio-Rad Laboratories quarterly total liabilities year-on-year change?
Over the past year, BIO quarterly total liabilities has changed by -$763.96 M (-21.47%)